Kris M. White

13.3k total citations
19 papers, 824 citations indexed

About

Kris M. White is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Kris M. White has authored 19 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Molecular Biology and 6 papers in Infectious Diseases. Recurrent topics in Kris M. White's work include Influenza Virus Research Studies (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and interferon and immune responses (5 papers). Kris M. White is often cited by papers focused on Influenza Virus Research Studies (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and interferon and immune responses (5 papers). Kris M. White collaborates with scholars based in United States, Russia and Australia. Kris M. White's co-authors include Adolfo Garcı́a-Sastre, Megan L. Shaw, Randy A. Albrecht, Ivan Marazzi, Alexander Rialdi, Lars Pache, Sven Heinz, Michael G.B. Hayes, Christopher Benner and Lorane Texari and has published in prestigious journals such as Cell, Journal of Virology and Scientific Reports.

In The Last Decade

Kris M. White

19 papers receiving 821 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kris M. White United States 13 415 229 209 173 87 19 824
Ralf Bartenschlager Germany 7 248 0.6× 261 1.1× 333 1.6× 168 1.0× 36 0.4× 9 813
Zhenlong Liu China 15 326 0.8× 172 0.8× 220 1.1× 307 1.8× 32 0.4× 48 854
Scott K. Johnson United States 17 292 0.7× 344 1.5× 214 1.0× 201 1.2× 36 0.4× 31 796
Muhan Huang China 8 447 1.1× 94 0.4× 458 2.2× 128 0.7× 32 0.4× 14 884
G. Lynn Law United States 22 926 2.2× 140 0.6× 138 0.7× 195 1.1× 90 1.0× 32 1.3k
Mohsan Saeed United States 19 322 0.8× 402 1.8× 451 2.2× 146 0.8× 27 0.3× 44 1.1k
Hanjun Zhao Hong Kong 15 406 1.0× 311 1.4× 457 2.2× 171 1.0× 19 0.2× 31 1.0k
Punya Shrivastava-Ranjan United States 15 298 0.7× 237 1.0× 677 3.2× 109 0.6× 28 0.3× 25 1.1k
Jingfang Mu China 13 546 1.3× 87 0.4× 504 2.4× 298 1.7× 59 0.7× 30 1.2k
John G. Purdy United States 13 284 0.7× 247 1.1× 91 0.4× 143 0.8× 43 0.5× 26 628

Countries citing papers authored by Kris M. White

Since Specialization
Citations

This map shows the geographic impact of Kris M. White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kris M. White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kris M. White more than expected).

Fields of papers citing papers by Kris M. White

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kris M. White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kris M. White. The network helps show where Kris M. White may publish in the future.

Co-authorship network of co-authors of Kris M. White

This figure shows the co-authorship network connecting the top 25 collaborators of Kris M. White. A scholar is included among the top collaborators of Kris M. White based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kris M. White. Kris M. White is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Xiang, Yufei, Jialu Xu, Briana L McGovern, et al.. (2024). Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy. Cell. 187(24). 6966–6980.e23. 11 indexed citations
2.
Rosales, Romel, Briana L McGovern, Myosotys Rodriguez, et al.. (2024). Nirmatrelvir and molnupiravir maintain potent in vitro and in vivo antiviral activity against circulating SARS-CoV-2 omicron subvariants. Antiviral Research. 230. 105970–105970. 1 indexed citations
3.
Kottur, Jithesh, Kris M. White, Myosotys Rodriguez, et al.. (2023). Structures of SARS-CoV-2 N7-methyltransferase with DOT1L and PRMT7 inhibitors provide a platform for new antivirals. PLoS Pathogens. 19(7). e1011546–e1011546. 5 indexed citations
4.
Rosales, Romel, Briana L McGovern, Myosotys Rodriguez, et al.. (2022). SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules. Pharmaceuticals. 15(12). 1448–1448. 2 indexed citations
5.
Le, Brian L., Gaia Andreoletti, Tomiko Oskotsky, et al.. (2021). Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19. Scientific Reports. 11(1). 12310–12310. 25 indexed citations
6.
Bafna, Khushboo, Kris M. White, Balasubramanian Harish, et al.. (2021). Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture. Cell Reports. 35(7). 109133–109133. 59 indexed citations
7.
White, Kris M., Matthew A. Esparza, Jue Liang, et al.. (2021). Aryl Sulfonamide Inhibits Entry and Replication of Diverse Influenza Viruses via the Hemagglutinin Protein. Journal of Medicinal Chemistry. 64(15). 10951–10966. 10 indexed citations
8.
Esparza, Matthew A., Amir Mor, Hanspeter Niederstrasser, et al.. (2020). Chemical intervention of influenza virus mRNA nuclear export. PLoS Pathogens. 16(4). e1008407–e1008407. 14 indexed citations
9.
Uccellini, Melissa B., Susana V. Bardina, María Teresa Sánchez-Aparicio, et al.. (2020). Passenger Mutations Confound Phenotypes of SARM1-Deficient Mice. Cell Reports. 31(1). 107498–107498. 34 indexed citations
10.
Amanat, Fatima, Kris M. White, Lisa Miorin, et al.. (2020). An In Vitro Microneutralization Assay for SARS‐CoV‐2 Serology and Drug Screening. Current Protocols in Microbiology. 58(1). e108–e108. 106 indexed citations
12.
Heinz, Sven, Lorane Texari, Michael G.B. Hayes, et al.. (2018). Transcription Elongation Can Affect Genome 3D Structure. Cell. 174(6). 1522–1536.e22. 281 indexed citations
13.
Wang, Juan, Ignacio Mena, Kris M. White, et al.. (2017). Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication. PLoS Pathogens. 13(9). e1006635–e1006635. 82 indexed citations
14.
White, Kris M., Hui Wang, Paul D. De Jesus, et al.. (2017). Broad Spectrum Inhibitor of Influenza A and B Viruses Targeting the Viral Nucleoprotein. ACS Infectious Diseases. 4(2). 146–157. 21 indexed citations
15.
Carpenter, Belinda, et al.. (2016). Who Leaves Suicide Notes? An Exploration of Victim Characteristics and Suicide Method of Completed Suicides in Queensland. Archives of Suicide Research. 20(2). 176–190. 13 indexed citations
16.
White, Kris M., Paul D. De Jesus, Zhong Chen, et al.. (2014). A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin Protein. ACS Infectious Diseases. 1(2). 98–109. 23 indexed citations
17.
White, Kris M., et al.. (2013). New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions. Antiviral Research. 100(1). 120–132. 39 indexed citations
18.
White, Kris M., Hua Peng, John Hay, & William T. Ruyechan. (2010). Role of the IE62 Consensus Binding Site in Transactivation by the Varicella-Zoster Virus IE62 Protein. Journal of Virology. 84(8). 3767–3779. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026